Clinical Trials Browser

Phase 1/2 × Uveal Melanoma × sargramostim × Clear all

NCT06626516 2025-11-28

Tebentafusp-tebn With LDT in Metastatic UM

Phase 1/2 Recruiting

Uveal Melanoma, Melanoma

NCT00089219 2014-11-20

Vaccine Therapy in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma

Phase 1/2 Completed

Uveal Melanoma, Melanoma